FindTrial
Sign In

Validity of KELIM score as a predictor of treatment outcome in patients diagnosed with advanced high grade serous ovarian cancer undergoing neoadjuvant chemotherapy and interval debulking surgery

Validity of KELIM score as a predictor of treatment outcome in patients diagnosed with advanced high grade serous ovarian cancer undergoing neoadjuvant chemotherapy and interval debulking surgery - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073568
Enrollment
112
Registered
2024-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C569- Malignant neoplasm of unspecifiedovary

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Histological Diagnosis: High Grade Serous Carcinoma (Ovary/Fallopian Tube/Peritoneum, HGSOC) FIGO Stage(2014): Stage III and Stage IV (including sub-stages) Will undergo the complete treatment regimen of neoadjuvant chemotherapy followed by interval debulking surgery and completion of remaining chemotherapy at TMCK

Exclusion criteria

Exclusion criteria: - Histological subtype other than HGSOC - Recurrent HGSOC - Unable to receive the complete treatment regimen due to any reason

Design outcomes

Primary

MeasureTime frame
To calculate the correlation of KELIM score with histopathological chemotherapy response score (CRS), the surrogate marker of treatment outcomeTimepoint: 16 months—

Secondary

MeasureTime frame
To calculate the correlation of KELIM score with - Surgical complexity score (SCS), - Completeness of cytoreduction score (CC) and - Progression free survival (PFS). Timepoint: 6 months—

Countries

India

Contacts

Public ContactDeepti S B

Tata Medical center , Kolkata

deepti.sb@tmckolkata.com919611145292

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026